Rheu/GI Therapeutic Area Lead

Pfizer•New York City, NY

About The Position

As a key member of the Specialty Care Leadership team, the US Rhu/GI TA Lead oversees Pfizer’s Rhu/GI portfolio, including Velsipity and Xeljanz. The role sets portfolio strategy, maximizes business performance and patient impact, and leads the Rhu/GI brands and portfolio functions, including brand leads, strategy, access integration, and TLEL. The lead is accountable for portfolio performance, the franchise P&L, and the annual operating plan. The role oversees an organization of approximately 15 colleagues, including approximately seven direct reports, and works across commercial and corporate functions to advance the portfolio and evaluate future growth opportunities.

Requirements

  • Bachelor’s degree required.
  • At least 12 years of pharmaceutical experience, including US market experience.
  • Demonstrated strategic acumen and bold-move thinking.
  • Proven ability to manage complex markets and projects.
  • Strong people leadership and demonstrated ability to lead through change.
  • Demonstrated ability to challenge the status quo.
  • Experience leading and motivating cross-functional teams, with direct or indirect experience.
  • Mastery of P&L and strong financial acumen.
  • Strong executive presence and experience with senior-level executives.
  • Ability to problem-solve and make decisions in a fast-paced environment.
  • Deep experience in the US market and understanding of US payer and rebating dynamics.
  • Prior team leadership required.

Nice To Haves

  • MBA preferred.
  • Experienced leader of leaders strongly preferred.
  • I&I experience preferred, but not required.

Responsibilities

  • Develop an end-to-end, portfolio-level strategy for the Rhu/GI franchise, including brand marketing, access strategy, patient support, and sales approach.
  • Own and understand all components of the brands and gross-to-net (GTN), and be accountable for performance and delivery across two brands.
  • Partner across the organization to accelerate Velsipity growth while delivering the Xeljanz loss-of-exclusivity (LOE) plan to optimize organizational return.
  • Own the Rhu/GI franchise P&L and assess key metrics on an ongoing basis.
  • Partner with sales, customer engagement, medical, legal, and access leads to set priorities and identify growth or optimization opportunities.
  • Identify opportunities to challenge the status quo and grow portfolio assets.
  • Partner with relevant organizations to establish Pfizer as a leader in the space.
  • Lead the annual operating plan, including revenue and expense recommendations.
  • Oversee an organization of approximately 15 colleagues, including approximately seven direct reports, with a collaborative, people-first approach and support team members’ growth.
  • Partner with Global Commercial Strategy, R&D, and business development to evaluate future growth opportunities for the therapeutic area.

Benefits

  • 401(k) plan with Pfizer matching contributions and an additional Pfizer Retirement Savings Contribution.
  • Paid vacation, holidays, and personal days.
  • Paid caregiver, parental, and medical leave.
  • Medical, prescription drug, dental, and vision coverage.
  • Participation in Pfizer’s Global Performance Plan, with a bonus target of 25% of base salary.
  • Eligibility to participate in Pfizer’s share-based long-term incentive program.
  • Relocation assistance may be available based on business needs and/or eligibility.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service